a significant trendP = 0.035
DRA in 1 cohort revealed a significant trend between sTG and SAH risk only in the linear model (Model 1, P = 0.035), with a decreasing risk of 54.0% (95% CI 5.5%~77.6%, P = 0.035) per mmol/L sTG increase (Fig. 5 D; Table 2 ).